OVERVIEW

Biomarkers in Immunotherapy Treatment Decision Making: Advancing Personalized Medicine in Oncology is organized by Power-Pak C.E. - Continuing Education for Pharmacists & Pharmacy Technicians and will be held from Dec 28, 2018 - Dec 28, 2019.

Credits: 1.0 hours (0.10 ceu)

Target Audience:
This accredited activity has been designed for oncology pharmacists and other pharmacists who manage or interact with oncology patients.

Goal:
To enhance oncology pharmacists' skills and knowledge in the use of biomarkers in immune-oncology treatment decision making, to personalize therapy thus optimizing care and outcomes.

Educational Objectives:
• Describe the potential biomarkers being examined to predict response to immunotherapy, specifically immune checkpoint inhibitors.
• Assess the variety of biomarker assessments available to determine biomarker status in patients.
• Discuss strategies for the potential selection of immune checkpoint inhibitors in consideration of biomarkers in specific patient situations.

Additional details will be posted as soon as they are available.